Assignee
CEL SCI CORP
US·12 granted patents·5 pending applications·146 citations·filing 1994–2021
Top patents by PatentIndex Score
17 records- 0186US7256254B2Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditionsCEL SCI CORP·Filed 2005·Granted Aug 14, 2007·6 cites·4 claims
- 0286US6995237B1Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditionsCEL SCI CORP·Filed 2000·Granted Feb 7, 2006·23 cites·1 claims
- 0383US6896879B2Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixtureCEL SCI CORP·Filed 2003·Granted May 24, 2005·20 cites·4 claims
- 0479US5652342AHeterofunctional cellular immunological reagents, vaccines containing same and methods for the use of sameCEL SCI CORP·Filed 1994·Granted Jul 29, 1997·41 cites·5 claims
- 0576US6951647B2T cell binding ligand peptides and method of inducing a cellular immune responseCEL SCI CORP·Filed 2001·Granted Oct 4, 2005·3 cites·9 claims
- 0672US6287565B1Modified HGP-30 heteroconjugates, compositions and methods of useCEL SCI CORP·Filed 2000·Granted Sep 11, 2001·2 cites·10 claims
- 0768US6096315AHeterofunctional cellular immunological reagents, vaccines containing same and methods for the use of sameCEL SCI CORP·Filed 1995·Granted Aug 1, 2000·21 cites·18 claims
- 0865US7199216B1Peptide constructs for treating autoimmune and related diseasesCEL SCI CORP·Filed 2000·Granted Apr 3, 2007·1 cites·1 claims
- 0957US6572860B1Immunogenic conjugated polypeptide for treatment of herpes simplex virusCEL SCI CORP·Filed 1998·Granted Jun 3, 2003·13 cites·8 claims
- 1054US2006257420A1Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditionsCEL SCI CORP·Filed 2006·Application pending·0 cites
- 1154US2021268101A1NOVEL PEPTIDES FOR VACCINATION AND TREATMENT OF 2019-nCoV INFECTIONSCEL SCI CORP·Filed 2021·Application pending·0 cites
- 1252US6268472B1Modified HGP-30 peptides, conjugates, compositions and methods of useCEL SCI CORP·Filed 2000·Granted Jul 31, 2001·8 cites·6 claims
- 1351US2008131396A1Method for altering the CD4/CD8 ratio and the mononuclear cellular infiltrate into a tumorCEL SCI CORP·Filed 2006·Application pending·0 cites
- 1450US6093400AModified HGP-30 peptides, conjugates, compositions and methods of useCEL SCI CORP·Filed 1996·Granted Jul 25, 2000·6 cites·18 claims
- 1544US2006257357A1Method for modulating HLA class II tumor cell surface expression with a cytokine mixtureCEL SCI CORP·Filed 2005·Application pending·0 cites
- 1639US6103239AModified HGP-30 heteroconjugates, compositions and methods of useCEL SCI CORP·Filed 1996·Granted Aug 15, 2000·2 cites·4 claims
- 1737US2008063625A1Method for Managing Cholesterol with a Serum-Free and Mitogen-Free Cytokine MixtureCEL SCI CORP·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CEL SCI CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →